Key provisions
- The antifraud prohibition (Section 25401). It is unlawful to buy or sell a security by written or oral communication containing an untrue statement of material fact or a misleading omission. Liability against a statutory seller does not require proof that the misstatement was intentional or negligent.
- The civil remedy (Section 25501) — with privity. The violator is liable to the person who bought from or sold to that person, who may seek rescission (consideration paid, plus legal-rate interest, less income received) or damages. The defense is reasonable care, on which the defendant bears the burden. Because the remedy runs between actual counterparties, aftermarket purchasers generally cannot use it.
- Mandatory attorneys' fees (A.B. 511, 2021). For violations on or after January 1, 2022, the court must award reasonable attorneys' fees and costs to a prevailing purchaser or seller under Section 25501 (and to those who prove a non-registration claim under Section 25503) — aligning California with Washington on fee-shifting.
- Control persons and aiders (Sections 25504, 25504.1). Controlling persons, partners, officers, directors, and materially-aiding employees or broker-dealers are jointly and severally liable unless they had no knowledge of, or reasonable grounds to believe, the facts. Separate aider-and-abettor liability under Section 25504.1 requires intent to deceive or defraud.
- Market manipulation (Sections 25400, 25500). For manipulative conduct affecting market price, a willful participant is liable to those who traded at the affected price — the route for aftermarket purchasers who lack privity for a Section 25501 claim.
- Deadlines (Section 25506). A fraud action must be brought within five years after the transaction or two years after discovery of the facts, whichever expires first.
Insights for investors
- Privity decides your path. If you bought directly from the wrongdoer, Section 25501 is powerful and does not require proving intent. If you bought in the aftermarket, you look instead to the manipulation statutes or to federal 10b-5.
- Fee-shifting is now on your side. Since the 2021 amendment, prevailing investors recover fees and costs by mandate.
- Two clocks, whichever is shorter. Five years from the transaction or two years from discovery — the shorter one controls.
Insights for VCs and fund managers
- Control-person liability without intent. Under Section 25504 a controlling investor or director can be jointly liable for a seller's violation without any showing of intent, subject to the knowledge/reasonable-grounds defense.
- Aiding liability is narrower but intentional. Section 25504.1 reaches those who materially assist with intent to deceive; unlike Section 25504, it turns on intent.
- Direct-deal disclosures are where privity bites for you. Because Section 25501 runs between counterparties, your representations to the investors you actually sell to are the exposure to manage.
Insights for investment advisers
- California has its own adviser antifraud rules. Corporations Code Section 25235 prohibits fraudulent, deceptive, and manipulative advisory conduct, separate from seller liability, and advisers must be properly registered.
- Recommendations can create aider exposure. Recommending a security whose offering materials were false can implicate Section 25504 or, where intent is present, Section 25504.1.
- Regulator and private claims run in parallel. The Department of Financial Protection and Innovation enforces the Law independently of any investor suit.
Where claims fail: the defense view
California's structure gives the defense distinct thresholds, several of which have no analog in Washington.
- The privity requirement under Section 25501 bars aftermarket purchasers who did not buy from, or sell to, the defendant.
- The reasonable-care defense lets a seller who neither knew nor reasonably could have known of the untruth avoid liability, with the burden on the defendant.
- Aider liability under Section 25504.1 requires intent to deceive; a claim pleaded only as material assistance, without intent, fails.
- The limitations period bars claims more than five years after the transaction or two years after discovery, whichever comes first.
Compliance takeaways
For issuers and advisers operating in California, the controls mirror the statute.
- Prioritize direct-deal disclosure, because Section 25501 exposure runs to the counterparties you actually sell to.
- Document reasonable care in the offering process to preserve the statutory defense.
- Advisers should keep conflicts disclosures and registration current and avoid the fraudulent or manipulative practices reached by Section 25235.
- Preserve the record needed to fix the discovery date, since the two-year clock turns on it.